Casimersen Market – Advancing Precision Therapies for...

agregó una foto Health

2026-10-14 09:06:52 -

Casimersen Market – Advancing Precision Therapies for Duchenne Muscular Dystrophy

The Casimersen Market reflects the development of targeted therapies for Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle weakness and deterioration. Casimersen is an antisense oligonucleotide designed to support exon 45 skipping in eligible patients with specific mutations in the DMD gene. By helping certain cells produce a shortened form of dystrophin,...

0 Commentarios 0 Acciones 21 Views 0 Vista previa